Publication | Open Access
Tranexamic acid is an active site inhibitor of urokinase plasminogen activator
43
Citations
17
References
2019
Year
Active Site InhibitorPathologyActive-site InhibitorCancer BiologyTumor BiologyDrug ResistanceSignaling PathwayCancer Cell BiologyCell SignalingInhibitory ActivityTranexamic AcidUrokinase Plasminogen ActivatorBiochemistryEndogenous Upa ActivityMechanism Of ActionPharmacologyCell BiologySignal TransductionKey Points TxaMedicineDrug Discovery
Key Points TXA is an active-site inhibitor of uPA. TXA attenuates MDA-MB-231 BAG cell migration and inhibits endogenous uPA activity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1